BrainsWay Ltd. (BWAY)
NASDAQ: BWAY · Real-Time Price · USD
17.27
+0.14 (0.82%)
At close: Dec 5, 2025, 4:00 PM EST
17.50
+0.23 (1.33%)
After-hours: Dec 5, 2025, 6:36 PM EST
BrainsWay Employees
BrainsWay had 120 employees as of December 31, 2024. The number of employees decreased by 14 or -10.45% compared to the previous year.
Employees
120
Change (1Y)
-14
Growth (1Y)
-10.45%
Revenue / Employee
$409,117
Profits / Employee
$52,067
Market Cap
333.92M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BWAY News
- 4 days ago - BrainsWay Ltd. (BWAY) Analyst/Investor Day Transcript - Seeking Alpha
- 11 days ago - BrainsWay to Host Virtual Analyst & Investor Day to Discuss the Company's Growth Strategy and Deep TMS™ Treatment December 1, 2025 - GlobeNewsWire
- 19 days ago - BrainsWay Launches First Clinical Trial of Deep TMS 360™ System for Alcohol Use Disorder - GlobeNewsWire
- 23 days ago - BrainsWay Receives FDA Clearance of Deep TMS™ as Adjunct Therapy for Major Depressive Disorder (MDD) in Adolescents Aged 15 to 21 - GlobeNewsWire
- 25 days ago - BrainsWay Ltd. (BWAY) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 25 days ago - BrainsWay Reports Third Quarter 2025 Financial Results and Operational Highlights - GlobeNewsWire
- 4 weeks ago - BrainsWay Reports National Institutes of Health Grant to Leading U.S. Research Team Investigating Accelerated Deep TMS for Treatment of Alcohol Use Disorder - GlobeNewsWire
- 5 weeks ago - BrainsWay to Report Third Quarter 2025 Financial Results on November 11, 2025 - GlobeNewsWire